Invention Grant
- Patent Title: Treatment of immune disorders
-
Application No.: US16828121Application Date: 2020-03-24
-
Publication No.: US11406669B2Publication Date: 2022-08-09
- Inventor: Silviu Itescu , Paul Simmons
- Applicant: Mesoblast International Sarl
- Applicant Address: CH Meyrin
- Assignee: Mesoblast International Sarl
- Current Assignee: Mesoblast International Sarl
- Current Assignee Address: CH Meyrin
- Agent John P. White
- Priority: AU2014902194 20140610,AU2014902257 20140613
- Main IPC: A61K35/28
- IPC: A61K35/28 ; A61K35/545 ; A61P29/00 ; A61P3/10 ; A61K38/17 ; A61K9/00 ; A61K38/18
Abstract:
The present disclosure relates to stem cells which express high levels of Angeopoetin-1 (Ang1) and uses thereof in inhibiting M1-type macrophage production and treating inflammatory disease such as diabetes.
Public/Granted literature
- US20200281984A1 TREATMENT OF IMMUNE DISORDERS Public/Granted day:2020-09-10
Information query
IPC分类:
